Want to join the conversation?
$TDS maintained its 2016 outlook for total operating revenue in a range of $3.9Bil and $4.1Bil. CEO LeRoy Carlson Jr. said the company continues to see strong customer adoption of Equipment Installment Plans, which increased equipment sales revenues.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.